论文信息 - An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab. - 字舞流文

An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.

A. Kennedy | M. Lindorfer | M. Solga | P. Foley | T. Schuman | W. Sutherland | R. Taylor | Amos W Chi | R. Taylor